CareFusion Launches EnVe(TM) Ventilator: 10-Pound High-Performance Critical Care Ventilator
13 Octobre 2009 - 5:00PM
PR Newswire (US)
New ventilator technology provides versatility, portability and may
help to improve patient care by reducing the need for multiple or
transport ventilators SAN DIEGO, Oct. 13 /PRNewswire-FirstCall/ --
CareFusion Corporation (NYSE: CFN), a new clinical and medical
products corporation, today announced the launch of the EnVe(TM)
ventilator - a high-performance critical care ventilator for
pediatric and adult patients. Weighing only 10 pounds, the EnVe
ventilator is 70-80 pounds lighter than other intensive care
ventilators and offers the latest in portable and ventilation
technology to help hospitals increase the quality of patient care
and decrease costs. The EnVe ventilator is unique in the
marketplace due to its versatility and ability to meet the varied
ventilation needs of clinicians. The modular design and reduced
weight of the EnVe system allows the ventilator to easily detach
and move with patients throughout the hospital, as necessary, and
reduces the need for and associated costs with multiple ventilators
during transport. Additionally, the device has the capability to
manage non-invasive or mask-ventilated patients, allowing patients
to be maintained on a single life support device throughout their
hospital stay. By keeping patients on one ventilator, clinicians
can better manage and care for patients by not breaking the
ventilator circuit or downgrading ventilation treatment, which may
help to reduce the risk of ventilator associated pneumonia and
possibly other adverse events. At the heart of the EnVe ventilator
is the device's patented ActivCore(TM) technology - the basis for
its powerful, compact and portable design. The ActivCore gas
delivery system features unprecedented miniaturization and blower
technology to provide high-end critical care ventilation while
enabling independence from wall air systems. In addition, the
ActivCore technology features a hot, swappable four-hour battery
for extended patient transport capabilities. "The EnVe ventilator's
patented technology is a giant leap forward in the ventilation
market," said David Schlotterbeck, chairman and CEO of CareFusion.
"Unlike previous generations of ventilators, the EnVe system allows
clinicians to provide the most critically ill pediatric and adult
patients with the highest level of care through a light-weight and
portable ventilator system." Beyond critical care ventilation, the
EnVe ventilator provides integrated monitoring and clinical tools
to assist clinicians in best managing and caring for patients. To
help move patients off of ventilators as quickly as possible, the
EnVe ventilator incorporates a Spontaneous Breathing Trial (SBT)
which provides data that helps clinicians to make informed
decisions about weaning patients from ventilation. The device also
features a pulse oximeter to monitor a patient's pulse rate and
oxygen saturation level during transport situations. The EnVe
ventilator successfully completed its first user preference
evaluations in August 2009 at Summerlin Hospital in Las Vegas and
Duke Medical Center in Durham, N.C., and in September 2009 at North
Memorial Hospital in Minneapolis. "We were honored to have had
Summerlin Hospital Respiratory Department as the first clinical
site for the EnVe ventilator," said Jeff Ghan, RRT, manager,
Respiratory Therapy at Summerlin Hospital in Las Vegas, Nev.
"During our evaluation we found the EnVe ventilator to be extremely
versatile and to provide the distinct advantage of safe patient
transport throughout the hospital. The ventilator fulfills a much
needed function for patient safety and ease of use." "The EnVe
ventilator is representative of many product innovations that
CareFusion is introducing to provide measurable improvements in
patient care and address some of the most urgent needs in health
care globally, including infection prevention and medication
errors," said Schlotterbeck. For more information on the EnVe
ventilator, please visit the EnVe product page at
http://www.carefusion.com/ under the Products and Services tab.
About CareFusion Corporation CareFusion (NYSE:CFN) is a global
corporation serving the health care industry with products and
services that help hospitals measurably improve the safety and
quality of care. The company develops market-leading technologies
including Alaris® IV pumps, Pyxis® automated dispensing and patient
identification systems, AVEA® and Pulmonetic Systems ventilation
and respiratory products, ChloraPrep® for infection prevention and
MedMined(TM) services for infection surveillance, neurological
monitoring and diagnostic products, V. Mueller® surgical
instruments, and an extensive line of products that support
interventional medicine. CareFusion employs more than 15,000 people
across its global operations. More information may be found at
http://www.carefusion.com/. DATASOURCE: CareFusion Corporation
CONTACT: Jim Mazzola of CareFusion Corporation, +1-858-617-1203, ;
or Aimee DeVoll, +1-314-552-6744, , for CareFusion Corporation; or
Investors, Carol Cox of CareFusion Corporation, +1-858-617-2020,
Web Site: http://www.carefusion.com/
Copyright